Andolino C, Cotul E, Xianyu Z, Li Y, Bhat D, Ayers M
Res Sq. 2024; .
PMID: 39678343
PMC: 11643320.
DOI: 10.21203/rs.3.rs-5510550/v1.
Loman B, Russart K, Grant C, Lynch A, Bailey M, Pyter L
BMC Cancer. 2022; 22(1):245.
PMID: 35248004
PMC: 8897840.
DOI: 10.1186/s12885-022-09274-0.
Madhav A, Andres A, Duong F, Mishra R, Haldar S, Liu Z
Oncogene. 2018; 37(32):4385-4397.
PMID: 29717261
PMC: 6085281.
DOI: 10.1038/s41388-018-0278-0.
Huang D, Li T, Wang L, Zhang L, Yan R, Li K
Cell Res. 2016; 26(10):1112-1130.
PMID: 27644987
PMC: 5113304.
DOI: 10.1038/cr.2016.109.
Kapoor N, Naufahu J, Tewfik S, Bhatnagar S, Garg R, Tewfik I
Integr Cancer Ther. 2016; 16(1):74-84.
PMID: 27252077
PMC: 5736069.
DOI: 10.1177/1534735416651968.
Ascent to altitude as a weight loss method: the good and bad of hypoxia inducible factor activation.
Palmer B, Clegg D
Obesity (Silver Spring). 2013; 22(2):311-7.
PMID: 23625659
PMC: 4091035.
DOI: 10.1002/oby.20499.
Is there a role for carbohydrate restriction in the treatment and prevention of cancer?.
Klement R, Kammerer U
Nutr Metab (Lond). 2011; 8:75.
PMID: 22029671
PMC: 3267662.
DOI: 10.1186/1743-7075-8-75.
Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.
Camps C, Iranzo V, Bremnes R, Sirera R
Support Care Cancer. 2006; 14(12):1173-83.
PMID: 16819628
DOI: 10.1007/s00520-006-0097-7.
Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Gebbia V, Testa A, Gebbia N
Br J Cancer. 1996; 73(12):1576-80.
PMID: 8664133
PMC: 2074540.
DOI: 10.1038/bjc.1996.297.
Nutritional assessment reflects muscle energy metabolism in gastric carcinoma.
Symreng T, Larsson J, Schildt B, WETTERFORS J
Ann Surg. 1983; 198(2):146-50.
PMID: 6870371
PMC: 1353071.
DOI: 10.1097/00000658-198308000-00006.
Energy expenditure in malnourished cancer patients.
Knox L, Crosby L, Feurer I, Buzby G, Miller C, Mullen J
Ann Surg. 1983; 197(2):152-62.
PMID: 6824369
PMC: 1353103.
DOI: 10.1097/00000658-198302000-00006.
[Pathogenesis and therapy of malnutrition in oncology].
Ollenschlager G
Z Ernahrungswiss. 1982; 21(2):124-45.
PMID: 6810564
DOI: 10.1007/BF02021387.
Whole body protein synthesis and turnover in normal man and malnourished patients with and without known cancer.
Norton J, Stein T, Brennan M
Ann Surg. 1981; 194(2):123-8.
PMID: 6789786
PMC: 1345227.
DOI: 10.1097/00000658-198108000-00001.
Resting energy expenditure in controls and cancer patients with localized and diffuse disease.
Arbeit J, Lees D, Corsey R, Brennan M
Ann Surg. 1984; 199(3):292-8.
PMID: 6703790
PMC: 1353395.
DOI: 10.1097/00000658-198403000-00008.
Tube feeding of cancer patients treated with chemotherapy.
De Vries E, Kreumer W, Schippers D, Mulder N
Med Oncol Tumor Pharmacother. 1985; 2(3):219-24.
PMID: 3934475
DOI: 10.1007/BF02934551.
Metabolic effects of nutritional support to cancer patients.
Lindmark L, Ekman L
Med Oncol Tumor Pharmacother. 1985; 2(3):213-7.
PMID: 3934474
DOI: 10.1007/BF02934550.
Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients.
Drott C, Svaninger G, Lundholm K
Ann Surg. 1988; 208(5):645-50.
PMID: 3190291
PMC: 1493794.
DOI: 10.1097/00000658-198811000-00017.
Malignant disease: nutritional implications of disease and treatment.
Holmes S, Dickerson J
Cancer Metastasis Rev. 1987; 6(3):357-81.
PMID: 3121201
DOI: 10.1007/BF00144270.
The metabolic environment of cancer.
Argiles J, Azcon-Bieto J
Mol Cell Biochem. 1988; 81(1):3-17.
PMID: 3050448
DOI: 10.1007/BF00225648.
Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomas.
Mulligan H, Tisdale M
Br J Cancer. 1991; 63(5):719-22.
PMID: 1674876
PMC: 1972399.
DOI: 10.1038/bjc.1991.162.
